ClinicalTrials.Veeva

Menu

RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population

Abbott logo

Abbott

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: CRM Device

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.

Enrollment

5,379 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patient is implanted with a CRM device
  • Patient has no documented history of AF (3 months prior to enrollment)
  • Patient is >18 years of age
  • Patient has life expectancy of >24 months

Trial design

5,379 participants in 1 patient group

No history of AF
Description:
Patient should not have had a documented history of AF for a period of 3 months prior to enrollment.
Treatment:
Device: CRM Device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems